Designating November 2024 as "American Diabetes Month".

Legislation Details

Designates November 2024 as “American Diabetes Month.”
Acknowledges that approximately 38.4 million individuals in the U.S. have diabetes and 97.6 million have prediabetes.
Recognizes diabetes as a serious chronic condition affecting all demographics.
Notes that certain racial and ethnic groups are disproportionately affected by diabetes.
States that 23% of individuals with diabetes in the U.S. are undiagnosed.
Reports that 11.6% of the U.S. population has diabetes, including 29.2% of those aged 65 and older.
Highlights that nearly 1 in 4 veterans receiving care from the Department of Veterans Affairs have diabetes.
Indicates a 40% lifetime risk of developing type 2 diabetes for U.S. adults.
Cites the American Diabetes Association’s report of $412.9 billion in medical costs associated with diagnosed diabetes in 2022.
Mentions that 1 in 4 insulin users reduce their usage due to high costs.
States that diabetes care accounted for 25% of U.S. healthcare spending in 2022.
Notes that medical costs for individuals with diabetes are 2.6 times higher than for those without.
Acknowledges that there is currently no cure for diabetes, but effective management and treatment exist.
Encourages public awareness of diabetes prevention and treatment options.
Supports diabetes education and early detection of symptoms and risk factors.
Advocates for research, treatment, and prevention to reduce the prevalence of all types of diabetes.
Recognizes the need to address healthcare access barriers that increase diabetes risk in certain communities.

Designating November 2024 as "American Diabetes Month".

Cosponsors